| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2009PNAS..10613445T |
| P356 | DOI | 10.1073/PNAS.0901944106 |
| P932 | PMC publication ID | 2726354 |
| P698 | PubMed publication ID | 19651619 |
| P5875 | ResearchGate publication ID | 26713911 |
| P50 | author | John Andersson | Q55293542 |
| P2093 | author name string | Rui Wang | |
| Heather Ramsey | |||
| Derya Unutmaz | |||
| Ethan M Shevach | |||
| Dat Q Tran | |||
| P2860 | cites work | The GARP gene encodes a new member of the family of leucine-rich repeat-containing proteins | Q24313285 |
| CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner | Q24656647 | ||
| Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
| Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology | Q28138090 | ||
| Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma | Q28266887 | ||
| Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins | Q28280925 | ||
| Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression | Q28593882 | ||
| Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins | Q30487560 | ||
| TGF-beta and regulatory T cell in immunity and autoimmunity | Q33722462 | ||
| Latent-TGF-beta: an overview | Q34251623 | ||
| Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma | Q35792001 | ||
| Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype | Q36059631 | ||
| Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice | Q36117987 | ||
| CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness | Q36370807 | ||
| Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures | Q37201964 | ||
| Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas | Q38313599 | ||
| Gene amplifications associated with the development of hormone-resistant prostate cancer | Q38450128 | ||
| Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer | Q39896205 | ||
| Structure and developmental expression of mouse Garp, a gene encoding a new leucine-rich repeat-containing protein. | Q41193486 | ||
| TGF-beta latency: biological significance and mechanisms of activation | Q41487221 | ||
| Characterization of the binding of transforming growth factor-beta 1, -beta 2, and -beta 3 to recombinant beta 1-latency-associated peptide | Q44617709 | ||
| TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice | Q44714971 | ||
| Usher syndrome in the Samaritans: strengths and limitations of using inbred isolated populations to identify genes causing recessive disorders. | Q50507468 | ||
| Activation requirements for the induction of CD4+CD25+ T cell suppressor function | Q56903555 | ||
| Amplification of the BRCA2 Pathway Gene EMSY in Sporadic Breast Cancer Is Related to Negative Outcome | Q57287473 | ||
| Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease | Q57849197 | ||
| Role and Regulation of the Serum- and Glucocorticoid-Regulated Kinase 1 in Fertile and Infertile Human Endometrium | Q59102101 | ||
| Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3 | Q60452054 | ||
| New gene in the homologous human 11q13-q14 and mouse 7F chromosomal regions | Q68069200 | ||
| Release and activation of platelet latent TGF–β in blood clots during dissolution with plasmin | Q71803700 | ||
| 11q13 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5. | Q73510704 | ||
| Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas | Q79401919 | ||
| Cutting Edge: Immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-beta-dependent manner | Q79984729 | ||
| Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta | Q80358435 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Leucine rich repeat containing 32 | Q21108890 |
| regulation of transforming growth factor beta activation | Q22301626 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 13445-13450 | |
| P577 | publication date | 2009-07-27 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells | |
| P478 | volume | 106 |
| Q34810896 | 3G11 expression in CD4+ T cell-mediated autoimmunity and immune tolerance |
| Q35008222 | A cluster of coregulated genes determines TGF-beta-induced regulatory T-cell (Treg) dysfunction in NOD mice |
| Q96136732 | A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by Treg cells |
| Q35633815 | A microRNA profile of human CD8(+) regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes |
| Q58111833 | Activation of latent transforming growth factor-β1, a conserved function for pregnancy-specific beta 1-glycoproteins |
| Q34142273 | Alterations in gene array patterns in dendritic cells from aged humans |
| Q35639525 | Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP. |
| Q88561517 | Autism-associated neuroligin-4 mutation selectively impairs glycinergic synaptic transmission in mouse brainstem synapses |
| Q52331790 | B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex. |
| Q40066040 | Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment |
| Q46717839 | Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8. |
| Q34579613 | C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells |
| Q50281162 | CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures. |
| Q34407365 | CD4(+)CD25(+)Foxp3(+)IFNγ(+) Treg are immunosuppressive in vitro and increase with intensity of the alloresponse in pretransplant MLC. |
| Q48227794 | CD4+ CD25+ GARP+ regulatory T cells display a compromised suppressive function in patients with dilated cardiomyopathy. |
| Q37515698 | CD4+CD25+ T regulatory cells activated during feline immunodeficiency virus infection convert T helper cells into functional suppressors through a membrane-bound TGFβ / GARP-mediated mechanism |
| Q37054806 | CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection. |
| Q36512608 | Canonical Wnt signaling in megakaryocytes regulates proplatelet formation |
| Q34745518 | Cell-autonomous function of Runx1 transcriptionally regulates mouse megakaryocytic maturation |
| Q28075479 | Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94 |
| Q38266807 | Clinical Impact of Regulatory T cells (Treg) in Cancer and HIV. |
| Q26774657 | Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy |
| Q41057184 | Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases Tregs |
| Q37046528 | Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients. |
| Q55267021 | Comparative Analysis of the Regulatory T Cells Dynamics in Peripheral Blood in Human and Porcine Polytrauma. |
| Q56898066 | Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood |
| Q90647950 | Cryo-EM structure of the αvβ8 integrin reveals a mechanism for stabilizing integrin extension |
| Q40964133 | Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA. |
| Q26745695 | Cutting the brakes on hematopoietic regeneration by blocking TGFβ to limit chemotherapy-induced myelosuppression |
| Q57463606 | Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction |
| Q49514455 | Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs. |
| Q37683126 | Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C |
| Q36195159 | Donor-specific CD8+ Foxp3+ T cells protect skin allografts and facilitate induction of conventional CD4+ Foxp3+ regulatory T cells |
| Q92489299 | EMSY expression affects multiple components of the skin barrier with relevance to atopic dermatitis |
| Q37640251 | Eda haplotypes in three-spined stickleback are associated with variation in immune gene expression. |
| Q64912598 | Effect of GARP on osteogenic differentiation of bone marrow mesenchymal stem cells via the regulation of TGFβ1 in vitro. |
| Q39691555 | Electronic Sorting of Immune Cell Subpopulations Based on Highly Plastic Genes |
| Q88953756 | Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells |
| Q35080090 | Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses |
| Q35998238 | Engineering an "infectious" T(reg) biomimetic through chemoselective tethering of TGF-β1 to PEG brush surfaces |
| Q45874015 | Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice. |
| Q37639474 | Expression of GARP Is Increased in Tumor-Infiltrating Regulatory T Cells and Is Correlated to Clinicopathology of Lung Cancer Patients |
| Q84376771 | Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells |
| Q42181657 | FOXP3 Expression in GARP-Transduced Helper T Cells Is Not Associated with FOXP3 TSDR Demethylation |
| Q33673969 | FOXP3 and GARP (LRRC32): the master and its minion |
| Q40745379 | FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children. |
| Q36715704 | Feline glycoprotein A repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+)CD25(+) regulatory T cells and mediates AIDS lentivirus-induced T cell immunodeficiency |
| Q38115990 | Flow-cytometric analysis of rare antigen-specific T cells |
| Q42655696 | Forkhead-Box-P3 Gene Transfer in Human CD4+ T Conventional Cells for the Generation of Stable and Efficient Regulatory T Cells, Suitable for Immune Modulatory Therapy |
| Q35005900 | Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells |
| Q27008912 | From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines |
| Q93092183 | Functional Genomics for the Identification of Modulators of Platelet-Dependent Thrombus Formation |
| Q60315850 | Functional Interrogation of Primary Human T Cells via CRISPR Genetic Editing |
| Q38202990 | Functional dynamics of Foxp3⁺ regulatory T cells in mice and humans. |
| Q92257584 | GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma Multiforme |
| Q51538952 | GARP inhibits allergic airway inflammation in a humanized mouse model. |
| Q89776672 | GARP is a key molecule for mesenchymal stromal cell responses to TGF-β and fundamental to control mitochondrial ROS levels |
| Q35010258 | GARP is regulated by miRNAs and controls latent TGF-β1 production by human regulatory T cells |
| Q102141402 | GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β |
| Q35827521 | GARP regulates the bioavailability and activation of TGFβ. |
| Q36842852 | GARP-TGF-β complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo |
| Q26752197 | GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing |
| Q43135547 | GP96 is a GARP chaperone and controls regulatory T cell functions. |
| Q43164249 | GP96: safeguarding Treg |
| Q39046334 | Garp as a therapeutic target for modulation of T regulatory cell function |
| Q52721830 | Gene Therapy With Regulatory T Cells: A Beneficial Alliance. |
| Q34003041 | Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease |
| Q36629111 | Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases |
| Q38195863 | Genome-wide association studies of atopic dermatitis |
| Q36017107 | Genome-wide association study identifies candidate genes for male fertility traits in humans |
| Q35671405 | Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci |
| Q47799426 | Glycoprotein A repetitions predominant (GARP) positively regulates transforming growth factor (TGF) β3 and is essential for mouse palatogenesis |
| Q36299565 | Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP. |
| Q38877648 | Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex |
| Q64251219 | Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease |
| Q26995345 | Homeostasis and function of regulatory T cells in HIV/SIV infection |
| Q35982318 | How Soluble GARP Enhances TGFβ Activation |
| Q52717949 | Human Cancer and Platelet Interaction, a Potential Therapeutic Target. |
| Q64277491 | Human LAP+GARP+FOXP3+ regulatory T cells attenuate xenogeneic graft versus host disease |
| Q92618041 | Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis |
| Q48105339 | IL-6 Inhibits Upregulation of Membrane-Bound TGF-β 1 on CD4+ T Cells and Blocking IL-6 Enhances Oral Tolerance |
| Q36392503 | Identification and characterization of latency-associated peptide-expressing γδ T cells |
| Q47235478 | Identification of key genes implicated in the suppressive function of human FOXP3+CD25+CD4+ regulatory T cells through the analysis of time‑series data |
| Q99408679 | Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers |
| Q49842867 | Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer |
| Q35099671 | Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study |
| Q91708036 | Impairment of NKG2D-Mediated Tumor Immunity by TGF-β |
| Q38194133 | Improving engraftment and immune reconstitution in umbilical cord blood transplantation |
| Q34999663 | In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance |
| Q40060026 | Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis. |
| Q35666235 | Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis |
| Q38220701 | Induced regulatory T cells in inhibitory microenvironments created by cancer |
| Q39572367 | Induction of latency-associated peptide (transforming growth factor-β(1)) expression on CD4+ T cells reduces Toll-like receptor 4 ligand-induced tumour necrosis factor-α production in a transforming growth factor-β-dependent manner. |
| Q58599390 | Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells |
| Q92784010 | Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment |
| Q90457405 | Intracellular and extracellular TGF-β signaling in cancer: some recent topics |
| Q40959589 | Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis |
| Q88207514 | Isolation of human antigen-specific regulatory T cells with high suppressive function |
| Q90628878 | LRRC33 is a novel binding and potential regulating protein of TGF-β1 function in human acute myeloid leukemia cells |
| Q35679014 | Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells. |
| Q33809300 | Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell Types |
| Q52682112 | Mechanisms of Oral Tolerance. |
| Q92263913 | Mechanisms of gastrointestinal allergic disorders |
| Q43277215 | Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg |
| Q41589465 | Membrane-bound Dickkopf-1 in Foxp3+ regulatory T cells suppresses T-cell-mediated autoimmune colitis |
| Q47103260 | Mesenchymal stem cells inhibit T cell activation by releasing TGF-β1 from TGF-β1/GARP complex |
| Q41817619 | Mesenchymal stromal cells express GARP/LRRC32 on their surface: effects on their biology and immunomodulatory capacity |
| Q28072712 | Monitoring of the Immune Dysfunction in Cancer Patients |
| Q36011105 | Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry |
| Q41293978 | Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo. |
| Q37881151 | Moving to tolerance: clinical application of T regulatory cells |
| Q33873469 | Murine CD4 T cells produce a new form of TGF-β as measured by a newly developed TGF-β bioassay |
| Q38165001 | Neuropilin 1: function and therapeutic potential in cancer |
| Q39615518 | Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta |
| Q38040614 | Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity |
| Q57155622 | New insights into the development of B cell responses: Implications for solid organ transplantation |
| Q80945963 | Oral tolerance |
| Q83849376 | Oral tolerance |
| Q34382264 | Overexpression of TGF-ß 1 gene induces cell surface localized glucose-regulated protein 78-associated latency-associated peptide/TGF-ß. |
| Q36070609 | PSG9 Stimulates Increase in FoxP3+ Regulatory T-Cells through the TGF-β1 Pathway |
| Q92603378 | Patrolling the vascular borders: platelets in immunity to infection and cancer |
| Q92286626 | Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes |
| Q37122171 | Peripheral and thymic foxp3(+) regulatory T cells in search of origin, distinction, and function |
| Q36183387 | Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft function |
| Q34263542 | Perspectives on Regulatory T Cell Therapies |
| Q38198735 | Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer |
| Q90659422 | Phenylbutyrate facilitates homeostasis of non-resolving inflammatory macrophages |
| Q41208347 | Platelets subvert T cell immunity against cancer via GARP-TGFβ axis. |
| Q64118859 | Polyphosphate as a Target for Interference With Inflammation and Thrombosis |
| Q50545420 | Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis. |
| Q38086869 | Potential of targeting TGF-β for organ transplant patients |
| Q47434187 | Prodomain-Growth Factor Swapping in the Structure of pro-TGF-β1. |
| Q37281835 | Reduced effectiveness of CD4+Foxp3+ regulatory T cells in CD28-deficient NOD.H-2h4 mice leads to increased severity of spontaneous autoimmune thyroiditis |
| Q26823216 | Regulation generation: the suppressive functions of human regulatory T cells |
| Q38851167 | Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins |
| Q39097028 | Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection |
| Q36890507 | Regulation of the expression of GARP/latent TGF-β1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation |
| Q60958243 | Regulatory Immune Mechanisms in Tolerance to Food Allergy |
| Q52715799 | Regulatory T Cells As Potential Targets for HIV Cure Research. |
| Q26742012 | Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting |
| Q35658799 | Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-β. |
| Q45066685 | Regulatory T cells in Acute and Chronic Kidney Diseases |
| Q30303089 | Regulatory T cells in central nervous system injury: a double-edged sword |
| Q27011336 | Regulatory T lymphocytes CD4(+): current issues |
| Q26865816 | Regulatory cells and transplantation tolerance |
| Q34146423 | Release of active TGF-β1 from the latent TGF-β1/GARP complex on T regulatory cells is mediated by integrin β8 |
| Q35242154 | Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells. |
| Q37062447 | Retinoic acid treated human dendritic cells induce T regulatory cells via the expression of CD141 and GARP which is impaired with age. |
| Q47969786 | Role of GARP in the activation of latent TGF-β1. |
| Q43058202 | Selective targeting of transforming growth factor-beta1 into TCR/CD28 signalling plasma membrane domains silences T cell activation |
| Q58785647 | Several Follicular Regulatory T Cell Subsets With Distinct Phenotype and Function Emerge During Germinal Center Reactions |
| Q52717208 | Shared and Unique Features Distinguishing Follicular T Helper and Regulatory Cells of Peripheral Lymph Node and Peyer's Patches. |
| Q33913016 | Signal peptide cleavage is essential for surface expression of a regulatory T cell surface protein, leucine rich repeat containing 32 (LRRC32). |
| Q64073753 | Significant association of CD4CD25Foxp3 regulatory T cells with clinical findings in patients with systemic lupus erythematosus |
| Q56891978 | Spatial distribution and function of T follicular regulatory cells in human lymph nodes |
| Q91943837 | Specificity, versatility, and control of TGF-β family signaling |
| Q90594661 | Structural biology of the TGFβ family |
| Q46197984 | Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells |
| Q47101209 | Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer |
| Q39024892 | Survival of porcine fibroblasts enhanced by human FasL and dexamethasone-treated human dendritic cells in vitro |
| Q37800935 | T regulatory cells in cancer: recent advances and therapeutic potential |
| Q39155183 | TGF-β Family Signaling in Connective Tissue and Skeletal Diseases |
| Q33566661 | TGF-β activation and function in immunity |
| Q55515390 | TGF-β in T Cell Biology: Implications for Cancer Immunotherapy. |
| Q33760756 | TGF-β induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction |
| Q96342890 | TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo |
| Q27012877 | TGF-β: guardian of T cell function |
| Q37967132 | TGF-β: the sword, the wand, and the shield of FOXP3(+) regulatory T cells |
| Q39155151 | Targeting TGF-β Signaling for Therapeutic Gain |
| Q40436303 | Targeting immunosuppression by Tregs with monoclonal antibodies against GARP |
| Q34519468 | Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling |
| Q52724249 | The Balance of Th1/Th2 and LAP+Tregs/Th17 Cells Is Crucial for Graft Survival in Allogeneic Corneal Transplantation. |
| Q30422620 | The C11orf30-LRRC32 region is associated with total serum IgE levels in asthmatic patients |
| Q47755372 | The Dual Role of Treg in Cancer |
| Q40721460 | The GARP/Latent TGF-β1 complex on Treg cells modulates the induction of peripherally derived Treg cells during oral tolerance |
| Q38589257 | The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms |
| Q45854995 | The Tregs' world according to GARP. |
| Q38008355 | The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells |
| Q50794921 | The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells. |
| Q21131158 | The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome |
| Q88159540 | The influence of hypoxia and IFN-γ on the proteome and metabolome of therapeutic mesenchymal stem cells |
| Q39277496 | The many ways tissue phagocytes respond to dying cells |
| Q35928046 | The molecular mechanisms of regulatory T cell immunosuppression |
| Q36302394 | The role of platelet and endothelial GARP in thrombosis and hemostasis |
| Q33654705 | Transcription profiles of the responses of chicken bursae of Fabricius to IBDV in different timing phases |
| Q96306728 | Transcriptional meta-analysis of regulatory B cells |
| Q36601077 | Transcriptome profiling of human FoxP3+ regulatory T cells |
| Q63407070 | Transforming Growth Factor-β Signaling in Immunity and Cancer |
| Q61805676 | Transient increase of activated regulatory T cells early after kidney transplantation |
| Q47141380 | Tregs: Where We Are and What Comes Next? |
| Q36711835 | Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration |
| Q37192207 | Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation |
| Q41247751 | Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy |
| Q52677986 | Unravelling the molecular basis for regulatory T-cell plasticity and loss of function in disease. |
| Q37695519 | tTregs, pTregs, and iTregs: similarities and differences |
| Q38814438 | αEβ7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative Colitis |
Search more.